Looking at monthly chat with 40% trading days remaining in Oct....

Looking at monthly chat with 40% trading days remaining in Oct.

The hype run due back Mar16 recorded 93% increase with 3 times more volume than we now traded. It was driven by speculation of FDA approval without having trial data. It kept running for a few more months into later that year.

In Aug 18 there’s a conservative run in anticipation of FDA success after investors realized how badly it can hurt, monthly growth was 40% with similar volume to this month. That trend was stopped pathetically the following month.

In April 19 the recovery finally came when Experien group finally lodged FDA application some of the investors including me started to buy in, the growth was 100% with a low volume. The rise was consolidated in next few months.

Comparing to these three months in the history, RAP investors have not reached half of the historical hype for more hope of FDA and commercialization blue sky. We will have a journey of coming back and breakout of previous high first matching similar volume in 2016, within the rest of the 2019. The Oct month will be the middle of the hill looking back from next year.